Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares BRAF V600E-mutant non-small-cell lung cancer, Adenocarcinoma of the lung, Non-small cell lung cancer (KEGG map), ALK-positive non-small-cell lung cancer and the tags subtype-page, lung.
Shares A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed, Adenocarcinoma of the lung, ALK-positive non-small-cell lung cancer, Osimertinib and the tags subtype-page, lung.
Shares Adenocarcinoma of the lung, ALK-positive non-small-cell lung cancer, Osimertinib, Pemetrexed and the tags subtype-page, lung.
Shares AstraZeneca, Carboplatin and the tags subtype-page, lung.
Shares AstraZeneca, Carboplatin, Antibody-drug conjugate (ADC) and the tags subtype-page, lung.
Shares Non-small-cell lung cancer and the tags subtype-page, lung.
Shares Sarcomatoid carcinoma of the lung, Adenocarcinoma of the lung, Pemetrexed, Carboplatin and the tags subtype-page, lung.
Shares Adenocarcinoma of the lung, Pemetrexed, EGFR-mutated non-small-cell lung cancer, EGFR and the tags subtype-page, lung.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.